Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Visscher

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcomeP J Anne de Pagter, Rob Schuurman, Henk Visscher, et al.
Journal of Lipid Research|May 6, 2003
Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1Cheryl L Wellington, Liam R Brunham, Steven Zhou, et al.
Pharmacogenomics|August 1, 2015
Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in childrenHenk Visscher, S Rod Rassekh, George S Sandor, et al.
Nature Genetics|November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapyColin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.
Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
Blood Advances|February 8, 2022
Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemiaLinde Dekker, Friso G Calkoen, Yilin Jiang, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcomeP J Anne de Pagter, Rob Schuurman, Henk Visscher, et al.
Journal of Lipid Research|May 6, 2003
Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1Cheryl L Wellington, Liam R Brunham, Steven Zhou, et al.
Pharmacogenomics|August 1, 2015
Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in childrenHenk Visscher, S Rod Rassekh, George S Sandor, et al.
Nature Genetics|November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapyColin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.
Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
Blood Advances|February 8, 2022
Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemiaLinde Dekker, Friso G Calkoen, Yilin Jiang, et al.
Pageof 3